Cargando…

Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients

BACKGROUND: Malignant gliomas are lethal cancers, highly dependent on angiogenesis and treatment options and prognosis still remain poor for patients with recurrent glioblastoma multiforme (GBM). Ephs and ephrins have many well-defined functions during embryonic development of central nervous system...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lin-Fang, Fokas, Emmanouil, Juricko, Janko, You, An, Rose, Frank, Pagenstecher, Axel, Engenhart-Cabillic, Rita, An, Han-Xiang
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292196/ https://www.ncbi.nlm.nih.gov/pubmed/18366728 http://dx.doi.org/10.1186/1471-2407-8-79

Ejemplares similares

Roles of EphA2 Receptor in Angiogenesis Signaling Pathway of Glioblastoma Multiforme
por: Baharuddin, Wan Noor Ainun, et al.
Publicado: (2018)

Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020)

Siah1 proteins enhance radiosensitivity of human breast cancer cells
por: He, Hai-Tao, et al.
Publicado: (2010)

EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma
por: Offenhäuser, Carolin, et al.
Publicado: (2018)

EphA5 and EphA6: regulation of neuronal and spine morphology
por: Das, Gitanjali, et al.
Publicado: (2016)

Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
por: Hatano, Manabu, et al.
Publicado: (2004)

Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model
por: Bhatia, Shilpa, et al.
Publicado: (2015)

EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2
por: Cui, Shuang, et al.
Publicado: (2021)

Targeting EphA2 in cancer
por: Xiao, Ta, et al.
Publicado: (2020)

The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
por: Zapata-Mercado, Elmer, et al.
Publicado: (2022)

EphA7 isoforms differentially regulate cortical dendrite development
por: Leonard, Carrie E., et al.
Publicado: (2020)

EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells
por: Dong, Xiao-Dong, et al.
Publicado: (2023)

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia
por: Charmsaz, Sara, et al.
Publicado: (2015)

Roles of EphA2 in Development and Disease
por: Park, Jeong Eun, et al.
Publicado: (2013)

Modulation of EphA7 and pEphA7 Protein Expression: Potential Biomarkers for Early Detection of Hepatocellular Carcinoma
por: Priya, Shivani, et al.
Publicado: (2022)

The EphA1 and EphA2 Signaling Modulates the Epithelial Permeability in Human Sinonasal Epithelial Cells and the Rhinovirus Infection Induces Epithelial Barrier Dysfunction via EphA2 Receptor Signaling
por: Shin, Jae Min, et al.
Publicado: (2023)

EphA7 promotes myogenic differentiation via cell-cell contact
por: Arnold, Laura L, et al.
Publicado: (2020)

EphA2 bears plasticity to tumor invasion
por: Sugiyama, Nami, et al.
Publicado: (2013)

Protein kinase A can block EphA2 receptor–mediated cell repulsion by increasing EphA2 S897 phosphorylation
por: Barquilla, Antonio, et al.
Publicado: (2016)

Development of an In-House EphA2 ELISA for Human Serum and Measurement of Circulating Levels of EphA2 in Hypertensive Patients with Renal Dysfunction
por: Murakoshi, Maki, et al.
Publicado: (2022)

Complementary expression of EphA7 and SCO-spondin during posterior commissure development
por: Stanic, Karen, et al.
Publicado: (2014)

Ligand-dependent EphA7 signaling inhibits prostate tumor growth and progression
por: Li, Shibao, et al.
Publicado: (2017)

The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer
por: Zhang, Wenfan, et al.
Publicado: (2022)

A Novel Occulta-Type Spina Bifida Mediated by Murine Double Heterozygotes EphA2 and EphA4 Receptor Tyrosine Kinases
por: Abdullah, Nor Linda, et al.
Publicado: (2017)

EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?
por: Cioce, Mario, et al.
Publicado: (2021)

Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4
por: Royet, Amélie, et al.
Publicado: (2017)

Comparison of carbon ion and photon reirradiation for recurrent glioblastoma
por: Lautenschlaeger, F. S., et al.
Publicado: (2021)

EphA3 Functions are Regulated by Collaborating Phosphotyrosine Residues
por: Shi, Guanfang, et al.
Publicado: (2010)

EphA4 is a prognostic factor in gastric cancer
por: Miyazaki, Kohji, et al.
Publicado: (2013)

Unliganded EphA3 dimerization promoted by the SAM domain
por: Singh, Deo R., et al.
Publicado: (2015)

Identification and characterization of Nanobodies targeting the EphA4 receptor
por: Schoonaert, Lies, et al.
Publicado: (2017)

Oncogenic Functions and Therapeutic Targeting of EphA2 in Cancer
por: Wilson, Kalin, et al.
Publicado: (2021)

Inhibition of EphA2 by Dasatinib Suppresses Radiation-Induced Intestinal Injury
por: Kim, Areumnuri, et al.
Publicado: (2020)

The putative tumor suppressor gene EphA7 is a novel BMI-1 target
por: Prost, Gaëlle, et al.
Publicado: (2016)

First-in-Human Trial of EphA2-Redirected CAR T-Cells in Patients With Recurrent Glioblastoma: A Preliminary Report of Three Cases at the Starting Dose
por: Lin, Qingtang, et al.
Publicado: (2021)

Differential Roles for EphA and EphB Signaling in Segregation and Patterning of Central Vestibulocochlear Nerve Projections
por: Allen-Sharpley, Michelle R., et al.
Publicado: (2013)

Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery
por: Stammes, Marieke A., et al.
Publicado: (2017)

Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer
por: Xia, Peng, et al.
Publicado: (2009)

Novel [(111)In]In-BnDTPA-EphA2-230-1 Antibody for Single-Photon Emission Computed Tomography Imaging Tracer Targeting of EphA2
por: Furukawa, Takenori, et al.
Publicado: (2023)

The Diagnostic Significance of PDGF, EphA7, CCR5, and CCL5 Levels in Colorectal Cancer
por: Üçüncü, Muhammed, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i4hu3djihiv5o0g1m82tiv2osn